Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.775 USD | +1.17% | -5.99% | -16.80% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
Financials (USD)
Sales 2024 * | 25.69M | Sales 2025 * | 16.86M | Capitalization | 325M |
---|---|---|---|---|---|
Net income 2024 * | -116M | Net income 2025 * | -149M | EV / Sales 2024 * | 1.07 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 286M | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
-2.94
x | P/E ratio 2025 * |
-2.48
x | Employees | 145 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.26% |
Latest transcript on C4 Therapeutics, Inc.
1 day | -4.65% | ||
1 week | -5.22% | ||
Current month | -5.60% | ||
1 month | -29.66% | ||
3 months | -57.05% | ||
6 months | +290.08% | ||
Current year | -16.46% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Kendra Adams
DFI | Director of Finance/CFO | 47 | 20-11-19 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 15-11-30 |
Glenn Dubin
BRD | Director/Board Member | 67 | 21-03-11 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,487 M€ | +8.44% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 4.71 | -0.21% | 92 355 |
24-06-06 | 4.72 | -4.65% | 1,068,793 |
24-06-05 | 4.95 | +1.02% | 1,093,569 |
24-06-04 | 4.9 | +1.24% | 1,487,383 |
24-06-03 | 4.84 | -3.20% | 1,366,559 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.46% | 325M | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- CCCC Stock